Table 2. Effect of various ascorbic acid level on sperm quality before freezing
Treatment1) | Sperm motility | Sperm viability | Sperm abnormality | PMI |
C0 (0%) | 67.42 ± 2.99a2) | 73.86 ± 2.04ab | 20.57 ± 2.37b | 66.57 ± 1.39a |
C1 (1%) | 68.29 ± 1.79ab | 75.71 ± 2.14bc | 18.57 ± 2.23ab | 69.43 ± 1.61b |
C2 (2%) | 70.29 ± 3.15b | 76.00 ± 2.45bc | 19.71 ± 1.79ab | 70.86 ± 1.68c |
C3 (3%) | 74.14 ± 4.34d | 79.29 ± 2.75c | 19.43 ± 1.81ab | 74.29 ± 1.60d |
C4 (4%) | 72.14 ± 2.27cd | 77.14 ± 1.77bc | 20.57 ± 1.61b | 72.43 ± 1.99cd |
C0 without addition of ascorbic acids; C1, with addition of 1 mg ascorbic acid into 100 mL extender; C2, with addition of 2 mg ascorbic acid into 100 mL extender; C3, with addition of 3 mg ascorbic acid into 100 mL extender, C4 with addition of 4 mg ascorbic acid into 100 mL extender.
Data show all mean ± standard error of means (n = 7).
Means in a column with different superscripts differ significantly at p < 0.05.
PMI, plasma membrane integrity.